93. Surg Clin North Am. 2018 Aug;98(4):747-760. doi: 10.1016/j.suc.2018.04.001. Epub 2018 May 30.Management of the Axilla in the Patient with Breast Cancer.Park KU(1), Caudle A(2).Author information: (1)Department of Breast Surgical Oncology, Division of Surgery, The University ofTexas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1434, Houston, TX 77030, USA.(2)Department of Breast Surgical Oncology, Division of Surgery, The University ofTexas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1434, Houston, TX 77030, USA. Electronic address: ascaudle@mdanderson.org.Evaluation of the axillary lymph nodes is critical in the management of breastcancer because it is a key predictor of survival outcome. Surgeons must not only be able to perform sentinel lymph node dissection with high accuracy but alsounderstand the implications of the results. Management of clinicallynode-negative and node-positive cases can vary significantly, as described inthis review. With emerging data, management of the axilla in breast cancer willcontinue to evolve.Copyright © 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.suc.2018.04.001 PMID: 30005771  [Indexed for MEDLINE]